|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q1 FY2022
As of Oct 31, 2021
|
Q3 FY2021
As of Apr 30, 2021
|
Q2 FY2021
As of Jan 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Website - net | ||||||||||||||||||||
| Operating lease - right-of-use asset - related party | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease liability - related party | ||||||||||||||||||||
| Investment payable | ||||||||||||||||||||
| Deferred revenue – related party | ||||||||||||||||||||
| Notes payable – related party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable – related party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity (Deficit) | ||||||||||||||||||||
| Series A, convertible preferred stock, $0.0001 par value, 200,000 shares authorized, no shares are issued and outstanding at April 30, 2026 and July 31, 2025. | ||||||||||||||||||||
| Total series A, convertible preferred stock, $0.0001 par value, 200,000 shares authorized, no shares are issued and outstanding at April 30, 2026 and July 31, 2025. | ||||||||||||||||||||
| Common Stock, $0.0001 par value; 10,000,000,000 shares authorized, 2,049,621,210 and 1,049,621,210 issued and outstanding, at April 30, 2026 and July 31, 2025, respectively. | ||||||||||||||||||||
| Treasury Stock, 80,000,000 and 0 shares held at April 30, 2026 and July 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity (Deficit) | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity (Deficit) | ||||||||||||||||||||
Loading...